| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C2orf47 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SYNRG | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FAH | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MXRA8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CARF | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PPP2R2C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | EIF3J | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | COMTD1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PGBD2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | KIN | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
